FlandersBio offers an up-to-date life sciences database with detailed information about all FlandersBio members.
FlandersBio beschikt over een geüpdate life sciences databank met een gedetailleerd overzicht van alle FlandersBio-ledenbedrijven.
Flen Pharma develops innovative topical products for improving the quality of life of patients that suffer from infections or inflammations. Flen Pharma started its activities in wound care - including burns, venous and diabetic ulcers, bedsores, grazes and post-operative wounds - and wound-bed preparation.
Flen Pharma was established as a result of research performed by its CEO Philippe Sollie, a pharmacist, during the 1990s. Activities focus on the discovery and development of novel wound treatments that significantly enhance the healing process, provide improved patient comfort and offer advanced methods in the clinical setting.
Products currently on the market include Flamigel®, Extracalm®, Flaminal® Hydro and Flaminal® Forte, which are based on the principle of moist wound healing. Flaminal® Hydro and Flaminal® Forte are Enzyme Alginogels®, which are based on a patented antimicrobial enzyme system. Flamirins® is an isotonic, slightly acidic wound rinse solution used in hospital and home care settings.
Ongoing research at the company’s laboratories is focused on the continuing development of products for the topical treatment of skin inflammation and infection.
The company's expertise is situated in following domains:
Flamigel®, Extracalm®, Flaminal® Hydro, Flaminal® Forte, Flamirins®